Clinical trial
Cost-effectiveness of Schema Therapy for Treatment-resistant Anxiety Disorders: A Multicentre RCT
NCT06298695 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cost-effectiveness of Schema Therapy for Treatment-resistant Anxiety Disorders: A Multicentre RCT
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2024
- Completion date
- December 31, 2030
- Enrollment
- 172 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.